Galectin Therapeutics Inc. (GALT) stock surges during pre-market trading. Here’s what you should know?
Galectin Therapeutics Inc. (NASDAQ: GALT) stock declined by 15.24% at the last close whereas the GALT stock price gains by 10.07% in the pre-market trading session. Galectin Therapeutics is devoted to the development of new medicines to help people with chronic liver disease and cancer live better lives. >> 7 Top Picks for the Post-Pandemic […]
Why The GALT Stock Rose Nearly 35% During Last Session?
At the end of Tuesday’s regular trading session, Galectin Therapeutics Inc. (NASDAQ: GALT) closed its shares at $1.80 up 34.85% or $0.73. The Galectin stock recorded a high volume of 18.09 million shares, compared to the average daily volume of 304.27K shares. GALT stock skyrocketed after launching a website designed for chronic diseases. What is […]
